EAGLE PHARMACEUTICALS, INC. 4
4 · EAGLE PHARMACEUTICALS, INC. · Filed Mar 22, 2017
Insider Transaction Report
Form 4
Edlin Richard A.
Director
Transactions
- Purchase
Common Stock
2017-03-22$79.44/sh+6,000$476,640→ 29,400 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $79.19 to $79.68, inclusive. The reporting person undertakes to provide to Eagle Pharmaceuticals, Inc., any security holder of Eagle Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).